BRIGHT PEAK THERAPEUTICS
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties.
BRIGHT PEAK THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.brightpeaktx.com
Total Employee:
11+
Status:
Active
Total Funding:
142 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Antelope Dx
Antelope Dx is a company developing a palm-sized diagnostic device for home testing.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
EMMAC Life Sciences
EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation.
Genespire
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
Infinited Fiber Company
Infinited Fiber Company is on a mission to make circular fashion and textiles an everyday reality
Kither Biotech
Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases
Legendairy Foods
Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.
Leyden Labs
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
Libre Foods
Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet and animals.
Loci Orthopaedics
A innovative orthopaedic implant for the treatment of thumb base arthritis.
MiroBio
MiroBio is Harnessing the natural control mechanisms of the immune system.
Nemis Technologies
NEMIS Technologies is a biotechnology company which develops diagnostic kits and solutions for accelerated microbiological.
NeoPhore
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.
Noema Pharma
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Numeric Biotech
Numeric Biotech is to build an innovative portfolio of first-in-class treatments that target multiple mechanisms of age related diseases.
Phaseform
Phaseform develops next-generation adaptive optics systems based on innovative hardware and software
Proxygen
Proxygen is a biotechnology firm specializing in protein degradation therapy for treatment of cancer and other life threatening dieseses.
Qorium
Qorium is a biotech company that provides premium, cell-cultured collagen-based leather.
Shattuck Labs
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
SparingVision
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
2021-06-01
Board_member
Board_member
2021-06-01
Board_member
2021-06-01
Board_member
2021-06-01
Board_member
Current Employees Featured
Jeffrey Bode Co-Founder & Scientific Advisor @ Bright Peak Therapeutics
Co-Founder & Scientific Advisor
Markus Enzelberger Co-Founder & Advisor @ Bright Peak Therapeutics
Co-Founder & Advisor
Fred Wiklund President & CEO @ Bright Peak Therapeutics
President & CEO
2021-04-01
Vijaya Pattabiraman Co-Founder, Senior Vice President & Head of Technology @ Bright Peak Therapeutics
Co-Founder, Senior Vice President & Head of Technology
Bertolt Kreft Chief Scientific Officer @ Bright Peak Therapeutics
Chief Scientific Officer
Founder
Investors List
Qatar Investment Authority
Qatar Investment Authority investment in Series B - Bright Peak Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Bright Peak Therapeutics
Versant Ventures
Versant Ventures investment in Series B - Bright Peak Therapeutics
BlackRock
BlackRock investment in Series B - Bright Peak Therapeutics
Invus
Invus investment in Series B - Bright Peak Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Bright Peak Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Bright Peak Therapeutics
Versant Ventures
Versant Ventures investment in Series A - Bright Peak Therapeutics
Official Site Inspections
http://www.brightpeaktx.com Semrush global rank: 5.63 M Semrush visits lastest month: 1.5 K
- Host name: 12.6.247.35.bc.googleusercontent.com
- IP address: 35.247.6.12
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Bright Peak Therapeutics"
About - Bright Peak Therapeutics
Overview Bright Peak Therapeutics is a clinical-stage biotechnology company advancing a broad portfolio of “next-generation” multi-functional PD-1 inhibitors, integrating both novel and …See details»
Home - Bright Peak Therapeutics
Allschwil, Switzerland. Switzerland Innovation Park Basel Area Hegenheimermattweg 167D 4123 Allschwil SwitzerlandSee details»
Bright Peak Therapeutics - Crunchbase Company …
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's …See details»
Careers - Bright Peak Therapeutics
We are an international research driven organization dedicated to discovering and developing cutting edge therapies that will make a difference in the lives of patients. ... then you can …See details»
Bright Peak Therapeutics AG – Swiss Biotech
Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies. We leverage our world-class protein engineering & conjugation platform to generate novel protein therapeutics for …See details»
Bright Peak Therapeutics - Datanyze
JohnSmith@brightpeaktx.com: 5: first_last: John_Smith@brightpeaktx.com: 6: first: John@brightpeaktx.com: 7: last: Smith@brightpeaktx.com: Your Questions, Our Answers Get …See details»
Bright Peak Therapeutics - Company Profile & Staff Directory
Bright Peak Therapeutics is a Biotechnology company located in Klybeckstrasse 191, WKL-136.4.93, Basel, CH with 52 employees. Access Bright Peak Therapeutics's email format and …See details»
Bright Peak Therapeutics - Switzerland Innovation Park Basel Area
Brightpeaktx.com. View all residents. Contact. Switzerland Innovation Park Basel Area AG Hegenheimermattweg 167A 4123 Allschwil, Switzerland +41 61 577 23 16 …See details»
Bright Peak Therapeutics AG
For more information, visit www.brightpeaktx.com. Contact: info@brightpeaktx.com. Immunotherapy. 17 Oct 2024 ... The statistics for drugs in the Pipeline is the current …See details»
Bright Peak Therapeutics Appoints John Schmid to its Board of …
April 17, 2025 –San Diego, California and Basel, Switzerland –Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional …See details»
Bright Peak Therapeutics AG (Bright Peak Therapeutics …
Mar 7, 2025 The company’s lead program, BPT567, is a bifunctional PD1-IL18 immunoconjugate currently in Phase 1/2a clinical trials. With headquarters in Basel, Switzerland, and San Diego, CA, Bright Peak is backed by top-tier …See details»
Aji Bio-Pharma | Ajinomoto Co., Inc. and Bright Peak Therapeutics …
SAN DIEGO, March 29, 2021 and TOKYO March 30, 2021 – Ajinomoto Co., Inc. (“Ajinomoto Co.”), a leading technology provider for biopharmaceuticals and the owner of Ajinomoto Bio …See details»
Bright Peak Therapeutics - Overview, News & Similar ... - ZoomInfo
Nov 9, 2022 www.brightpeaktx.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Bright Peak Presents New Data at AACR: BPT567 …See details»
Bright Peak Therapeutics - VentureRadar
Redox Scientific Unknown n/a Redox Scientific is a contract development and manufacturing organization (CDMO) specializing in providing comprehensive products and services to the …See details»
Bright Peak Therapeutics Company Overview, Contact Details ...
Nov 09, 2022 | brightpeaktx.com. Brightpeaktx launches BPT543. Additionally, using the same functionally optimized IL-18 payload that has been incorporated into BPT567, Bright Peak has …See details»
Bright Peak Therapeutics Announces the Appointment of Cancer ...
Prior, he was Chief Medical Officer at MacroGenics, where he led the company’s evolution of a fully-integrated clinical-stage cancer immunotherapy organization. Dr. Wigginton also held …See details»
How Bright Peak Transformed Purchasing + Update [Case Study]
Nov 6, 2023 This international research-driven organization is dedicated to developing novel therapies for the treatment of cancer and autoimmune diseases. Using its proprietary …See details»
Bright Peak Therapeutics Company Information - Seedtable
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Bright Peak Therapeutics Announces $107 Million Series B …
Jun 10, 2021 –Proceeds to advance company’s pipeline of next-generation cytokine immunotherapies––Laura Shawver, Christine Siu join as independent directors– June 10, …See details»
Bright Peak Therapeutics Announces $107 Million Series B
Jun 10, 2021 info@brightpeaktx.com. Recommended Reading. April 17, 2025 07:00 ET | Source: Bright Peak Therapeutics, Inc. Bright Peak Therapeutics Appoints John Schmid to its …See details»